Your browser doesn't support javascript.
loading
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination.
Carr, Ryan M; Duma, Narjust; McCleary-Wheeler, Angela L; Almada, Luciana L; Marks, David L; Graham, Rondell P; Smyrk, Thomas C; Lowe, Val; Borad, Mitesh J; Kim, George; Johnson, Geoffrey B; Allred, Jacob B; Yin, Jun; Lim, Vun-Sin; Bekaii-Saab, Tanios; Ma, Wen We; Erlichman, Charles; Adjei, Alex A; Fernandez-Zapico, Martin E.
Afiliação
  • Carr RM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
  • Duma N; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, WI, USA.
  • McCleary-Wheeler AL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Graham RP; Department of Laboratory Medicine Pathology, Mayo Clinic, Rochester, MN, USA.
  • Smyrk TC; Department of Laboratory Medicine Pathology, Mayo Clinic, Rochester, MN, USA.
  • Lowe V; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Borad MJ; Division of Hematology-Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Kim G; Division of Hematology-Oncology, The George Washington University, Washington, DC, USA.
  • Johnson GB; Division of Nuclear Medicine, Mayo Clinic, Rochester, MN, USA.
  • Allred JB; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Yin J; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Lim VS; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
  • Bekaii-Saab T; Division of Hematology-Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Ma WW; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
  • Erlichman C; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA.
  • Adjei AA; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA. Electronic address: adjei.alex@mayo.edu.
  • Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA; Department of Medical Oncology, Department of Oncology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55902, USA. Electronic address: fernanadezzapico.martin@mayo.edu.
Pancreatology ; 20(6): 1115-1122, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32778368
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático / Proteínas Hedgehog / Serina-Treonina Quinases TOR Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático / Proteínas Hedgehog / Serina-Treonina Quinases TOR Idioma: En Ano de publicação: 2020 Tipo de documento: Article